Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Independent Loss of Methylthioadenosine Phosphorylase (MTAP) in Primary Cutaneous T-Cell Lymphoma.
J Invest Dermatol. 2016 Jun;136(6):1238-1246. doi: 10.1016/j.jid.2016.01.028. Epub 2016 Feb 9.
J Invest Dermatol. 2016.
PMID: 26872600
Free article.
Contribution of STAT3 and RAD23B in Primary Sézary Cells to Histone Deacetylase Inhibitor FK228 Resistance.
Butler RM, McKenzie RC, Jones CL, Flanagan CE, Woollard WJ, Demontis M, Ferreira S, Tosi I, John S, Whittaker SJ, Mitchell TJ.
Butler RM, et al.
J Invest Dermatol. 2019 Sep;139(9):1975-1984.e2. doi: 10.1016/j.jid.2019.03.1130. Epub 2019 Mar 22.
J Invest Dermatol. 2019.
PMID: 30910759
Free article.
Item in Clipboard
Constitutive activation of STAT3 in Sézary syndrome is independent of SHP-1.
McKenzie RC, Jones CL, Tosi I, Caesar JA, Whittaker SJ, Mitchell TJ.
McKenzie RC, et al.
Leukemia. 2012 Feb;26(2):323-31. doi: 10.1038/leu.2011.198. Epub 2011 Aug 5.
Leukemia. 2012.
PMID: 21818116
Item in Clipboard
Downregulation of Fas gene expression in Sézary syndrome is associated with promoter hypermethylation.
Jones CL, Wain EM, Chu CC, Tosi I, Foster R, McKenzie RC, Whittaker SJ, Mitchell TJ.
Jones CL, et al.
J Invest Dermatol. 2010 Apr;130(4):1116-25. doi: 10.1038/jid.2009.301. Epub 2009 Sep 17.
J Invest Dermatol. 2010.
PMID: 19759548
Free article.
Item in Clipboard
Regulation of T-plastin expression by promoter hypomethylation in primary cutaneous T-cell lymphoma.
Jones CL, Ferreira S, McKenzie RC, Tosi I, Caesar JA, Bagot M, Whittaker SJ, Mitchell TJ.
Jones CL, et al.
J Invest Dermatol. 2012 Aug;132(8):2042-9. doi: 10.1038/jid.2012.106. Epub 2012 Apr 12.
J Invest Dermatol. 2012.
PMID: 22495182
Free article.
Item in Clipboard
Efficacy and Safety of Ixekizumab Versus Adalimumab in Biologic-naïve Patients With Active Psoriatic Arthritis and Moderate-to-severe Psoriasis: 52-week Results From the Randomized SPIRIT-H2H Trial.
Reich K, Kristensen LE, Smith SD, Rich P, Sapin C, Leage SL, McKenzie R, Schuster C, Riedl E, Gooderham M.
Reich K, et al.
Dermatol Pract Concept. 2022 Apr 1;12(2):e2022104. doi: 10.5826/dpc.1202a104. eCollection 2022 May.
Dermatol Pract Concept. 2022.
PMID: 35646453
Free PMC article.
Item in Clipboard
Cite
Cite